Sclerosing epithelioid fibrosarcoma: in‐depth review of a genetically heterogeneous tumor

KA Murshed, I Al‐Bozom, A Ammar - Apmis, 2021 - Wiley Online Library
First described in 1995 by Meis‐Kindbloom et al. as a variant of fibrosarcoma simulating
carcinoma, sclerosing epithelioid fibrosarcoma (SEF) is a malignant soft tissue sarcoma …

Sclerosing Epithelioid Fibrosarcoma

LM Warmke, W Yu, JM Meis - Surgical Pathology Clinics, 2024 - surgpath.theclinics.com
Sclerosing epithelioid fibrosarcoma (SEF) is a distinctive sarcoma that may arise in nearly
any soft tissue site or bone. While there has been past controversy as to whether it is related …

[HTML][HTML] Detection of sarcoma fusions by a next-generation sequencing based–ligation-dependent multiplex RT-PCR assay

MD Lanic, F Le Loarer, V Rainville, V Sater, M Viennot… - Modern Pathology, 2022 - Elsevier
Morphological, immunohistochemical, and molecular methods often need to be combined
for accurate diagnosis and optimal clinical management of sarcomas. Here, we have …

Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic …

B Xu, LM Rooper, JK Dermawan… - Genes …, 2022 - Wiley Online Library
Background Mesenchymal chondrosarcoma (MCS) is a rare translocation‐associated
sarcoma, driven by a canonical HEY1:: NCOA2 fusion. The tumors typically have a biphasic …

Novel low‐grade renal spindle cell neoplasm with HEY1::NCOA2 fusion that is distinct from mesenchymal chondrosarcoma

TI Miller, JG Mantilla, W Wang, YJ Liu… - Genes …, 2023 - Wiley Online Library
HEY1‐NCOA2 fusion is most described in mesenchymal chondrosarcoma. This is the first
case report of a primary renal spindle cell neoplasm of uncertain malignant potential with a …

Progressive insights into fibrosarcoma diagnosis and treatment: leveraging fusion genes for advancements

X Tang, X Hu, Y Wen, L Min - Frontiers in Cell and Developmental …, 2023 - frontiersin.org
Fibrosarcoma, originating from fibroblast cells, represents a malignant neoplasm that can
manifest across all genders and age groups. Fusion genes are notably prevalent within the …

Sclerosing epithelioid fibrosarcoma: a new mesenchymal non-meningothelial tumor involving the central nervous system?

T Wolf, V Sinnes, D Reita, A Chammas, J Gantzer… - Virchows Archiv, 2024 - Springer
The patient is a 50-year-old woman without comorbidity or notable medical history, including
a neoplasm excised in the past after detailed questioning about her clinical history. She …

[HTML][HTML] Mediastinal low-grade fibromyxoid sarcoma with FUS-CREB3L2 gene fusion

CM Williams, W Du, WE Mangano, L Mei - Cureus, 2021 - ncbi.nlm.nih.gov
Low-grade fibromyxoid sarcoma (LGFMS) is a rare subclass of sarcoma. Histologically, they
are characterized by bland-appearing fibroblastic spindle cells and are similar to sclerosing …

[HTML][HTML] Response to Immunotherapy in Sclerosing Epithelioid Fibrosarcoma: Case Report and Literature Review

AS Koerner, M Zhou, A Brook, SS Yoon, KN Ganjoo - Cureus, 2023 - ncbi.nlm.nih.gov
Sclerosing epithelioid fibrosarcoma (SEF) is an extremely rare subtype of sarcoma that
appears histologically low-grade yet usually has a clinically aggressive course with a high …

Sarcoma fibromixoide primario de colon transverso metastásico perforado

JL Beristain-Hernandez… - Revista Médica del …, 2021 - revistamedica.imss.gob.mx
Introducción: el sarcoma fibromixoide de bajo grado (LGFMS) se considera un tumor de
tejidos blandos raro, que tiene tendencia a surgir del tronco y de las extremidades …